Quince Therapeutics Inc
NASDAQ:QNCX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Quince Therapeutics Inc
NASDAQ:QNCX
|
US |
|
Alliance Media Holdings Inc
OTC:ADTR
|
US |
|
L
|
Leoni AG
XBER:LEO
|
DE |
|
G
|
Global Blood Therapeutics Inc
F:G5B
|
US |
|
R
|
RedcapTour Co Ltd
KOSDAQ:038390
|
KR |
|
Ioupay Ltd
ASX:IOU
|
AU |
|
M
|
Mostostal Warszawa SA
WSE:MSW
|
PL |
|
National Bank of Greece SA
ATHEX:ETE
|
GR |
|
Fortescue Metals Group Ltd
ASX:FMG
|
AU |
|
D
|
Distribuidora de Gas Cuyana SA
BCBA:DGCU2
|
AR |
|
Intelligent Living Application Group Inc
NASDAQ:ILAG
|
HK |
|
P
|
PCC Exol SA
WSE:PCX
|
PL |
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
AU |
|
M
|
Meshulam Levinstein Contracting & Engineering Ltd
TASE:LEVI
|
IL |
|
A
|
Atento SA
OTC:ATTOF
|
LU |
|
T
|
Total Soft Bank Ltd
KOSDAQ:045340
|
KR |
|
ABC Arbitrage SA
OTC:ABCCF
|
FR |
|
Y
|
Ybox Real Estate Ltd
TASE:YBOX
|
IL |
|
B
|
Bridger Aerospace Group Holdings Inc
NASDAQ:BAER
|
US |
|
A
|
Apple Inc
SGO:AAPL
|
US |
|
R
|
RMK Energy PT Tbk
IDX:RMKE
|
ID |
|
Neuropace Inc
NASDAQ:NPCE
|
US |
|
Paladin Energy Ltd
ASX:PDN
|
AU |
|
Yamaichi Electronics Co Ltd
TSE:6941
|
JP |
Shareholder Yield
Current shareholder yield for QNCX is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
QNCX Price
Quince Therapeutics Inc
| Average Annual Return | -7.39% |
| Standard Deviation of Annual Returns | 83.37% |
| Max Drawdown | -100% |
| Market Capitalization | 10m USD |
| Shares Outstanding | 55 680 000 |
| Percentage of Shares Shorted | 22.34% |
